Niagen Bioscience (NAGE) Non-Current Assets (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Non-Current Assets data on file, last reported at $9.2 million in Q1 2026.

• On a quarterly basis, Non-Current Assets rose 79.88% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $28.2 million, a 53.0% increase from a year earlier, with the FY2025 full-year figure at $9.6 million, up 129.89% from the prior year.
• Non-Current Assets for Q1 2026 stood at $9.2 million, down from $9.6 million in the prior quarter.
• Over the last five years, Non-Current Assets for NAGE reached as high as $9.6 million in Q4 2025 and fell as low as $4.2 million in Q4 2024.
• Historically, Non-Current Assets has averaged $6.4 million across 5 years, with a median of $6.3 million in 2023.
• Across the five-year window, Non-Current Assets tumbled 30.37% in 2024 and surged 129.89% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $7.5 million in 2022, then slipped by 27.5% to $5.4 million in 2023, then slipped by 23.09% to $4.2 million in 2024, then surged by 129.89% to $9.6 million in 2025, then decreased by 4.08% to $9.2 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $9.2 million in Q1 2026, $9.6 million in Q4 2025, and $4.5 million in Q3 2025.